← SynDRA
BRD-K28308851
SynDRA canonical compound SYN0062529 — structure-anchored drug synonym record
| Clinical phase | Preclinical |
| Primary target(s) | HRH3 |
| Mechanism of action | histamine receptor agonist |
All known targets
Mechanisms of action (all sources)
- histamine receptor agonist
Cross-references
Synonyms
- alpha-methylhistamine-dihydrobromide-(S)-(+)
- (S)-alpha-Methylhistamine
- (2S)-1-(1H-imidazol-5-yl)propan-2-amine
- (S)-alpha-MeHA
- Alpha-Methylhistamine-S
- Tocris-0572
- Lopac-H-128
- GTPL1238
- SCHEMBL4008535
- BDBM22905
- BDBM81972
- CHEBI:125525
- BDBM50472559
- PDSP1_000509
- PDSP2_000540
- AKOS006339244
- NCGC00015491-01
- NCGC00024659-01
- NCGC00024659-02
- CAS_75614-93-6
- (2S)-1-(1H-Imidazol-4-yl)-2-propanamine
- (2S)-1-(3H-imidazol-4-yl)propan-2-amine
- EN300-1817457
- BRD-K28308851-001-01-8
- BRD-K28308851-303-01-8
- (2S)-1-(1H-imidazol-5-yl)-2-propanamine
- methyl 2-{3-[2-(5-ethylpyridin-1(2H)-yl)ethyl]-1H-indol-2-yl}prop-2-enoate
- SR-01000597941-1
- (2S)-1-(1H-imidazol-5-yl)propan-2-amine;dihydrobromide
- (S)-1-(1H-Imidazol-4-yl)propan-2-amine dihydrobromide
- (S)-(+)-alpha-Methylhistamine dihydrobromide
- AKOS024458567
- (S)-1-(1H-Imidazol-4-yl)propan-2-aminedihydrobromide
- (s)-(+)--Methylhistamine
- SR-01000597941
- (S)-(+)-a-Methylhistamine dihydrobromide
Look up BRD-K28308851 in the interactive SynDRA portal →